Liminatus Pharma, Inc. (LIMN)
0.1876
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
0.3312
+0.14
(+76.55%)
After-Hours: 20:00
Liminatus Pharma Free Cash Flow : -11.99M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Oruka Therapeutics, Inc. | -91.19M |
| MapLight Therapeutics, Inc. | -164.26M |
| Kailera Therapeutics, Inc. | -- |
| Veracyte, Inc. | 155.34M |
| Insight Molecular Diagnostics, Inc. | -27.46M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.015M |
| Cash from Financing (Quarterly) | 3.585M |
| Free Cash Flow Per Share (Quarterly) | -0.056 |
| Free Cash Flow to Equity (Quarterly) | -2.015M |
| Free Cash Flow to Firm (Quarterly) | -1.997M |
| Free Cash Flow Yield | -225.5% |